European Society for Medical Oncology

Oncology & Cancer

Rare cancers: A growing focus of early-stage clinical trials

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumour types receive increasing attention, according to new research to be presented ...

page 6 from 34